Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

EK significantly improved wound healing and reduced infection in burn wounds.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

A gene mutation causes monilethrix in a Chinese family.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

A new keratin gene was found in mice, explaining hair growth.

The extracellular matrix affects where tumors can start in the body.

Increasing m6A levels can improve skin cell growth and wound healing.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Epidermal growth factor helps hair recover after chemotherapy.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Epiregulin can help hair grow and may be useful for treating hair loss.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.